D1 but not D2 dopamine receptors or adrenoceptors mediate dopamine-induced potentiation of N-methyl-d-aspartate currents in the rat prefrontal cortex
Section snippets
Acknowledgements
This work was supported by the Deutsche Forschungsgemeinschaft (IL 20/9-2). We are grateful to Dr. P. Scheibler and Mr. J.M. Guzman for methodological support.
References (28)
- et al.
The mesocortico-prefrontal dopaminergic neurons
Trends Neurosci.
(1984) The imbalanced brain: from normal behavior to schizophrenia
Biol. Psychiatry
(2000)- et al.
Dopamine modulation of synaptic transmission in rat prefrontal cortex: an in vitro electrophysiological study
Neurosci. Res.
(1994) - et al.
5-HT2 receptor or α-adrenoceptor activation induces axcitatory postsynaptic currents
Eur. J. Pharmacol.
(1999) - et al.
Dopamine–glutamate interactions in the prefrontal cortex of the conscious rat: studies on ageing
Mech. Ageing Dev.
(1997) - et al.
β-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase
Neuron
(1996) A direct projection from Ammon's horn to prefrontal cortex in the rat
Brain Res.
(1981)- et al.
Interaction between P2Y and NMDA receptors in layer V pyramidal neurons of the rat prefrontal cortex
Neuropharmacology
(2002) - et al.
Opposite modulation of cortical N-methyl-d-aspartate receptor-mediated responses by low and high concentrations of dopamine
Neuroscience
(1999) - et al.
Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex
Synapse
(1992)
Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex
Proc. Natl. Acad. Sci. U.S.A.
Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex
J. Neurophysiol.
A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system
Pflugers Arch.
Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization
J. Pharmacol. Exp. Ther.
Cited by (31)
An optimized method for adult zebrafish brain-tissue dissociation that allows access mitochondrial function under healthy and epileptic conditions
2021, Brain ResearchCitation Excerpt :A pool of 2 dissociated brains was used per sample (n = 6 samples/treatment). Next, samples were transferred to the chambers containing: HBSS or HBSS Mg2+ free + NMDA (NMDA final concentration of 10 mM, according to (Chen et al., 2003; Wirkner et al., 2004; Deshpande et al., 2008; Nagarkatti et al., 2010; Makinodan et al., 2013; Ivanov et al., 2015; Kim et al., 2016; Mikroulis et al., 2018). Cellular O2 consumption measurement was performed as described in 5.6 Section.
Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action
2009, Progress in Neuro-Psychopharmacology and Biological PsychiatryNeurotoxicity of HIV-1 Tat protein: Involvement of D1 dopamine receptor
2007, NeuroToxicologyMulti-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006, Pharmacology and TherapeuticsCitation Excerpt :Dopaminergic fibers innervating the frontal cortex, hippocampus, and basal ganglia fulfil major roles in the control of cognitive function and they are specifically implicated in the modulation of mnesic processes under conditions of stress. The actions of DA are expressed in interaction with cholinergic and, although less well defined, glutamatergic (NMDA receptor-mediated) mechanisms (Levin et al., 1990; Gasbarri et al., 1993; Nieoullon, 2002; Jay, 2003; Sesack et al., 2003; Pezze & Feldon, 2004; Seamans & Yang, 2004; Wirkner et al., 2004). Most attention has focussed on D1 receptors in view of their marked facilitatory influence upon mnemonic function (Castner et al., 2000; Granon et al., 2000; Nieoullon, 2002; Pezze & Feldon, 2004).
Dopamine D<inf>1</inf> receptor antagonism in the prelimbic cortex blocks the reinstatement of heroin-seeking in an animal model of relapse
2009, International Journal of Neuropsychopharmacology